SeraCare Introduces New Worldwide HIV Performance Panel

SeraCare Life Sciences SRLS announces the launch of its new Worldwide HIV Performance Panel. This new HIV panel presents a group of HIV positive plasma samples with diverse variants of HIV, allowing efficient evaluation of HIV assays against multiple strains of the virus. SeraCare's Worldwide HIV Performance Panel includes 20 members—17 are HIV-1 positive, covering 10 different subtypes, two are HIV-2 positive and one is negative. Plasma was sourced from Africa, Asia, Europe and Central America and includes rare and difficult to source HIV genotypes.